A detailed history of Ameriprise Financial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 13,840,108 shares of ABBV stock, worth $2.47 Billion. This represents 0.72% of its overall portfolio holdings.

Number of Shares
13,840,108
Previous 14,049,623 1.49%
Holding current value
$2.47 Billion
Previous $2.41 Billion 13.42%
% of portfolio
0.72%
Previous 0.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $34.3 Million - $41.8 Million
-209,515 Reduced 1.49%
13,840,108 $2.73 Billion
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $23.9 Million - $27.9 Million
-154,584 Reduced 1.09%
14,049,623 $2.41 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $1.93 Million - $2.2 Million
12,090 Added 0.09%
14,204,207 $2.59 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $17.3 Million - $19.5 Million
126,035 Added 0.9%
14,192,117 $2.2 Billion
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $26.7 Million - $30.9 Million
199,833 Added 1.44%
14,066,082 $2.1 Billion
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $113 Million - $140 Million
-851,539 Reduced 5.79%
13,866,249 $1.87 Billion
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $212 Million - $244 Million
1,463,681 Added 11.04%
14,717,788 $2.35 Billion
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $31 Million - $37.2 Million
224,116 Added 1.72%
13,254,107 $2.14 Billion
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $10.2 Million - $11.7 Million
75,787 Added 0.59%
13,029,991 $1.75 Billion
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $6.48 Million - $8.24 Million
47,114 Added 0.37%
12,954,204 $1.98 Billion
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $29.4 Million - $36.5 Million
-223,127 Reduced 1.7%
12,907,090 $2.09 Billion
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $286 Million - $362 Million
2,665,628 Added 25.47%
13,130,217 $1.77 Billion
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $302 Million - $343 Million
2,842,328 Added 37.29%
10,464,589 $1.13 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $82.7 Million - $92.1 Million
-786,065 Reduced 9.35%
7,622,261 $858 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $23.4 Million - $25.7 Million
228,338 Added 2.79%
8,408,326 $911 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $17 Million - $23 Million
211,677 Added 2.66%
8,179,988 $877 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $5.39 Million - $6.32 Million
-62,686 Reduced 0.78%
7,968,311 $697 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $51.8 Million - $69.3 Million
705,784 Added 9.63%
8,030,997 $789 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $61 Million - $92.5 Million
945,863 Added 14.83%
7,325,213 $558 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $2.31 Million - $2.89 Million
-31,981 Reduced 0.5%
6,379,350 $565 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $168 Million - $202 Million
2,664,786 Added 71.13%
6,411,331 $491 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $26.8 Million - $34.3 Million
407,876 Added 12.22%
3,746,545 $271 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $24.4 Million - $28.8 Million
-316,939 Reduced 8.67%
3,338,669 $268 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $10.1 Million - $12.4 Million
129,270 Added 3.67%
3,655,608 $338 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $75.1 Million - $83.5 Million
844,429 Added 31.49%
3,526,338 $547 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $199 Million - $235 Million
-2,216,636 Reduced 45.25%
2,681,909 $248 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $146 Million - $195 Million
-1,581,602 Reduced 24.41%
4,898,545 $464 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $68.9 Million - $75.6 Million
-769,441 Reduced 10.61%
6,480,147 $627 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $506 Million - $647 Million
7,249,588
7,249,588 $647 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.